AFDO RAPS Healthcare Products Collaborative
BIO
Willy Liou

Willy

Liou

Director of Regulatory Affairs

Amgen

Willy Liou is currently Director of Device Regulatory Affairs at Amgen overseeing global regulatory strategy and execution for combination products and human factors across all programs. Willy joined Amgen in 2013 at a time when the company was preparing for the first wave of combination product submissions. Prior to Amgen, Willy served at a Johnson and Johnson medical device company where he held positions in international regulatory affairs and quality compliance. He earned a B.S. in biochemistry from University of California, Irvine, and an M.S. in biotechnology from Johns Hopkins University.

2024 Combo Logo FDA

Back to agenda

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT Us

Have questions about our events, registration, CEUs, sponsorship, or something else?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative